Home By PE Sector Buyout True North gives Indian drugmaker Biocon Biologics $3bn valuation through stake buy

True North gives Indian drugmaker Biocon Biologics $3bn valuation through stake buy

By

-

January 7, 2020

830

Private equity investor True North has agreed an INR5.3bn ($74.6m) investment in Indian biosimilars drugmaker Biocon Bio

Technology partner